The 3rd Fluid & Imaging Biomarkers & Endpoints in Neuroscience Summit is dedicated to novel translatable neuroinflammatory and neurodegenerative biomarkers.
Topics
Harnessing mass spectrometry & ml models for assay validation & prediction of longitudinal outcomes
Translational & clinical utility & patient stratification in trials for more confident relevance of drugs to the patient
Integrating omics with biological understanding for efficient & specific biomarker ID
Harnessing biomarkers as surrogate endpoints in neuroscience trials for streamlined regulatory approvals
Improving biomarker sensitivity for more quantitative monitoring of disease progression & drug effect
